Antiretroviral Agents in HIV-1 (2018)

Antiretroviral Agents in HIV-1 Pocket Guide

DHHS HIV GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/370315

Contents of this Issue

Navigation

Page 11 of 29

12 Selecting a Treatment Regimen Table 5. Laboratory Monitoring Schedule for HIV-Infected Patients Before and After Initiation of ART a Laboratory Test Timepoint/Frequency of Testing Entry into Care ART Initiation b or Modification 2–8 Weeks After ART Initiation or Modification Every 3–6 Months HIV Serology If HIV diagnosis has not been confirmed CD4 Count During first 2 years of ART or if viremia develops while patient on ART or CD4 count <300 cells/mm 3 HIV Viral Load d e Resistance Testing f HLA-B*5701 Testing If considering ABC Tropism Testing If considering a CCR5 antagonist Hepatitis B Serology g,h,i (HBsAb, HBsAg, HBcAb total) May repeat if patient non-immune and not chronically infected with HBV h

Articles in this issue

Archives of this issue

view archives of Antiretroviral Agents in HIV-1 (2018) - Antiretroviral Agents in HIV-1 Pocket Guide